ALCLOMETASONE DIPROPIONATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for alclometasone dipropionate and what is the scope of patent protection?
Alclometasone dipropionate
is the generic ingredient in two branded drugs marketed by Fougera Pharms, Glenmark Pharms Ltd, and Taro, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for alclometasone dipropionate. Three suppliers are listed for this compound.
Summary for ALCLOMETASONE DIPROPIONATE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 3 |
| NDAs: | 8 |
| Drug Master File Entries: | 3 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 41 |
| Clinical Trials: | 1 |
| Patent Applications: | 5,216 |
| Drug Prices: | Drug price trends for ALCLOMETASONE DIPROPIONATE |
| What excipients (inactive ingredients) are in ALCLOMETASONE DIPROPIONATE? | ALCLOMETASONE DIPROPIONATE excipients list |
| DailyMed Link: | ALCLOMETASONE DIPROPIONATE at DailyMed |
Recent Clinical Trials for ALCLOMETASONE DIPROPIONATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| GlaxoSmithKline | Phase 2 |
Pharmacology for ALCLOMETASONE DIPROPIONATE
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for ALCLOMETASONE DIPROPIONATE
US Patents and Regulatory Information for ALCLOMETASONE DIPROPIONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | ALCLOMETASONE DIPROPIONATE | alclometasone dipropionate | CREAM;TOPICAL | 076587-001 | Sep 15, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fougera Pharms | ALCLOMETASONE DIPROPIONATE | alclometasone dipropionate | OINTMENT;TOPICAL | 076884-001 | Jul 18, 2005 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fougera Pharms | ALCLOMETASONE DIPROPIONATE | alclometasone dipropionate | CREAM;TOPICAL | 076973-001 | Jul 12, 2005 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Glenmark Pharms Ltd | ALCLOMETASONE DIPROPIONATE | alclometasone dipropionate | CREAM;TOPICAL | 079061-001 | Jun 23, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALCLOMETASONE DIPROPIONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Fougera Pharms | ACLOVATE | alclometasone dipropionate | CREAM;TOPICAL | 018707-001 | Dec 14, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Fougera Pharms | ACLOVATE | alclometasone dipropionate | OINTMENT;TOPICAL | 018702-001 | Dec 14, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
